InnovAge Holding Corp.

INNV ·Healthcare, Medical Care Facilities, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Revenue $853.7M $763.9M $688.1M $698.6M $637.8M $567.2M
Cost of Revenue
Gross Profit $153.6M $132.1M $101.3M $135.4M
Gross Margin 18.0% 17.3% 14.7% 19.4%
Operating Expenses
Research & Development
SG&A Expense $122.1M $111.3M $115.6M $101.7M $132.3M $58.5M
Operating Income $-29.8M $-23.2M $-49.4M $-4.4M $-12.3M $50.9M
Operating Margin -3.5% -3.0% -7.2% -0.6% -1.9% 9.0%
Interest Expense $2.5M $16.8M $14.6M
Pretax Income
Income Tax Expense $1.3M $1.4M $-7.2M $723.0K $9.8M $9.9M
Net Income $-30.3M $-21.3M $-40.7M $-6.5M $-44.0M $26.3M
Net Margin -3.6% -2.8% -5.9% -0.9% -6.9% 4.6%
EPS (Basic) $-0.22 $-0.16 $-0.30 $-0.05 $-0.36 $0.20
EPS (Diluted) $-0.22 $-0.16 $-0.30 $-0.05 $-0.36 $0.19
Shares Outstanding (Basic) 135.4M 135.9M 135.6M 135.5M 123.6M 132.6M
Shares Outstanding (Diluted) 135.4M 135.9M 135.6M 135.5M 123.6M 135.2M
Dividends Per Share